new post
StocksRunner logo
mail
search
 
menu
 
MacroGenics Com
$1.90
-2.06%
 
  Set Alerts  
  
  Overview  
  
  Comments  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Headlines  
 

MGNX Stock Analysis & IQ Rating | MacroGenics Com

 
 

MGNX

 

MacroGenics Com

$1.90

 
-$0.04 | -2.06%
 
Set Alerts
 
  Overview  
  
  Comments  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Headlines  
 
 
52W High
$2.49
 
 
MKT CAP
$117.66M
 
52W Low
$0.99
 
 
VOL
$538.87K
 
P/E Ratio
N/A
 
 
AVG VOL
$775.09K
 
RSI
58.61
 
 
TREND
Uptrend
 
 
 

MGNX Stock IQ

 
lock  Login to see MacroGenics Com (MGNX) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
 
 

MGNX Target Price

 
 
Not Enough Information
 
 
 
 

MGNX Price Performance

 
 

$1.73   (+9.83%)

$1.37   (+38.69%)

$1.78   (+6.74%)

$2.18   (-12.84%)

 
 
1year
6month
3month
1month

MGNX Analysts Opinion

Overall standing based on market and analyst consensus. menu Hover over the category for more information

Earnings

×

Earnings

Rating

×

Rating

Momentum

×

Momentum

MGNX Momentum Analysis Price value has negative momentum

Activity

×

Activity

Future

×

Future

MGNX Analysts Opinion

MGNX Analysts opinion is negative and it remained unchanged from the past 3 months

MGNX Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

17%
Consensus Rating
NA
Buy
Opinion
0%
Trend
Score
NA
Potential
Score
MGNX Street Sentiment

MGNX Street Sentiment is unimpressive and have negative views on the near-term outlook

MGNX Risk Level

MGNX has Low risk level

Risk Indicators

Price under $5
MGNX Risk Level
Low
LOW
HIGH

MGNX Performance Sentiment

Sentiments overview associated with events and the stock performance

17%
Positive
1 out of 6
events present
83%
Negative
5 out of 6
events present
Very Bullish
Bullish
Neutral
Bearish
Very Bearish

Key Price Levels

Average key support and resistance price levels

Support Price
$1.69
Resistance Price
N/A
Current Price Range
$1.90
$1.69
N/A
Show methods +
 
MGNX Latest Analysis +
 
 
FAQ About MGNX Stock Insights
 

What is MGNX current stock price?

What are MGNX stock strengths?

What is MGNX Risk Level?

What is MGNX market cap and volume?

What is MGNX current Stock IQ?

Should I buy MGNX stock right now?

Is MGNX a Strong Buy right now?

What does a 'Strong Buy' rating mean for MGNX?

What does a 'Strong Sell' rating mean for MGNX?

What factors influence MGNX's Stock IQ?

 
 
StocksRunner

Explore our MGNX Stock insights

  • In-Depth Market Analysis and Trends
  • Expert Insights on Market Dynamics
  • Tailored MGNX Stock Strategies
  • Effective Risk Management
 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive our MGNX Daily Alerts

Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

 
Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

 
Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

 
Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

 
About StocksRunner

Log In

Sign Up

Plans & Pricing

Contact Us

Terms of use

Privacy Policy

 
 
 
 

MGNX

 

MacroGenics Com

 
Set Alerts
 
 

Current Price

 

$1.90

 
-$0.04 | -2.06%
 
 
52W High
$2.49
 
 
MKT CAP
$117.66M
 
52W Low
$0.99
 
 
VOL
$538.87K
 
P/E Ratio
N/A
 
 
AVG VOL
$775.09K
 
RSI
58.61
 
 
TREND
Uptrend
 
 
 
  Overview  
  
  Comments  
  
  Insights  
  
   Risks   
  
  Rating  
  
  Chart  
  
  Analysts  
  
  Street  
  
  Sentiment  
 
 
 
 
user
 
 
 
 

MGNX Price Performance

 
 

$1.73   (+9.83%)

$1.37   (+38.69%)

$1.78   (+6.74%)

$2.18   (-12.84%)

 
 
1year
6month
3month
1month
 

MGNX Analysts Opinion

Overall standing per market and analyst expectations. menu Hover over the category for more information

Earnings

×

Earnings

Rating

×

Rating

Momentum

×

Momentum

MGNX Momentum Sentiment Price value has negative momentum

Activity

×

Activity

Future

×

Future

MGNX Analysts Opinion

MGNX Analysts opinion is negative and it remained unchanged from the past 3 months

MGNX Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

17%
Consensus Rating
NA
Buy
Opinion
0%
Trend
Score
NA
Potential
Score
MGNX Street Sentiment

MGNX Street Sentiment is unimpressive and have negative views on the near-term outlook

MGNX Risk Level

MGNX has Low risk level

Risk Indicators

Price under $5
MGNX Risk Level
Low
LOW
HIGH
MGNX Performance Sentiment
Sentiments overview associated with events and the stock performance.
17%
Positive
1 out of 6
events present
83%
Negative
5 out of 6
events present
Very Bullish
Bullish
Neutral
Bearish
Very Bearish

Key Price Levels

Average key support and resistance price levels

Support Price
$1.69
Resistance Price
N/A
Current Price Range
$1.90
$1.69
N/A
Show methods +
 
 
 
 

MGNX Stock IQ

 
 
 
lock  Login to unlock MacroGenics Com (MGNX) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
 
 
 

Target Price

 
 
 
 
 
 
 

Stock Insights

 
 
 

Not Enough Information

 
 
 

MGNX Latest Analysis

 
 
 

MacroGenics to Participate in Upcoming Investor Conferences. ROCKVILLE MD Feb. 26 2026 (GLOBE NEWSWIRE) -- MacroGenics Inc. (Nasdaq: MGNX) a biopharmaceutical company focused on developing innovative antibody-based therapeutics for the treatment of cancer today announced that the Companys management team will participate in the following investor conferences in March:

 

Thu Feb 26, 2026

$1.98 | +3.13%
 
Activity

Why Is MacroGenics Stock Sinking Tuesday?. MacroGenics Inc. (NASDAQ:MGNX) shares are down during Tuesday’.s premarket session following the announcement of a partial clinical hold on its Phase 2 LINNET study.The stock’.s decline comes as the company is working closely with the FDA to resolve safety concerns related to recent events in the trial.The United States Food and Drug Administration (FDA) on Monday placed a partial clinical hold on MacroGenics’. LINNET study which evaluate

 

Tue Feb 24, 2026

$1.73 | -1.14%
 
Momentum

MacroGenics drops after FDA partial clinical hold on lead program.

 

Tue Feb 24, 2026

$1.73 | -1.14%
 
Momentum

Why Is MacroGenics Stock Sinking Tuesday?. ) shares are down during Tuesday’.s premarket session following the announcement of a partial clinical hold on its Phase 2 LINNET study.The stock’.s decline comes as the company is the FDA to resolve safety concerns related to recent events in the trial.The United States Food and Drug Administration (FDA) on Monday placed a partial clinical hold on MacroGenics’. LINNET study which evaluates lorigerlimab in patients .The hold was initiate

 

Tue Feb 24, 2026

$1.73 | -1.14%
 
Momentum

MacroGenics Announces Pausing of Enrollment of New Study Participants in LINNET Trial. FDA has placed partial clinical hold on LINNET study of lorigerlimab in gynecologic cancer

 

Mon Feb 23, 2026

$1.75 | +2.94%
 
Activity
 
 
 
 
 
StocksRunner

Discover MGNX Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of MGNX. We're here to help you make informed investment decisions today.

 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Receive our MGNX Daily Alerts

Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

 
Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

MGNX Stock trends

MGNX Stock performance

MGNX Stock analysis

MGNX investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
StocksRunner logo
 

MGNX Alerts

Real-time signals powered by data
×

Price-Based

Triggers when the stock breaks through a known resistance level
 
Triggers when the stock drops below a key support level
 
Notifies if the stock moves up/down by a set percentage (e.g. ±5%)
 
Alerts when the stock hits a new high or low
 
Signals proximity to long-term highs or lows (e.g. within 5%)
 

Technical Indicator (Pro Plan)

Volume spikes 2x–3x above average. Indicates strong buying/selling pressure
 
Tracks large intraday swings, signaling potential opportunities or risk
 
Signals potential trend reversals or continuations
 
Long-term bullish/bearish trend signals from MA crossovers
 
RSI above 70 or below 30 to identify possible reversals
 
Signals momentum shifts
 

Fundamental Indicator (Master Plan)

Upcoming or just-released earnings reports
 
Alerts after results compared to expectations
 
Changes in rating or target price
 
New or changed dividends
 
Large trades by company insiders
 
M&A, lawsuits, product launches, etc
 
High volume/open interest in call/put contracts
 
Surge in mentions or sentiment shifts
 
 
Cancel
 
×
 
0/666
joker
 
Post
 
✕
 
StocksRunner logo
 

Don't Be a Sheep, Be a StocksRunner

 

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

 
StocksRunner thumbnail
 
 

Sign up for free and

continue analysing MGNX

 
Signup to Stocksrunner
 

Already a Member? Click here to Login

 

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

 
✕
 
StocksRunner logo
 

Don't Be a Sheep, Be a StocksRunner

 

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

 
StocksRunner thumbnail
 
 

Sign up for free and

continue analysing MGNX

 
Signup to Stocksrunner
 

Already a Member? Click here to Login

 

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.